Skip to main content

Table 2 Health outcomes assessed in the EU exposome projects

From: Unravelling the chemical exposome in cohort studies: routes explored and steps to become comprehensive

Health outcome HELIX HEALS EXPOsOMICS HBM4EU
Allergies/asthma Yes Yes   
Neurodevelopment Yes Yes   Ongoing
Weight development Yes Yes   
Obesity Yes Yes   
Type 2 diabetes Yes    
Neurodegenerative diseases Yes    
Cancer Yes   Yes Yes
Acute coronary events and blood pressure    Yes  
  1. Please refer to Additional file 1: Table S1 for a detailed overview regarding the characteristics of the used cohort studies including study design, sample size, age, time of enrolment, and gender ratio
\